| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Deutsches Krebsforschungszentrum, Forschungsschwerpunkt Angewandte Tumorvirologie
and2 Forschungsschwerpunkt Krebsentstehung und Differenzierung, Im Neuenheimer Feld 242, D-69120 Heidelberg, Germany
Using site-directed mutagenesis, we tested whether a potential integrin-binding site, (composed of the amino acids RGD) which is predicted in the adeno-associated virus 2 (AAV-2) capsid open reading frame (ORF), plays a role in the infectivity of AAV-2. Nucleotide sequencing of wild-type and mutant capsid protein-coding sequences, however, revealed discrepancies with the published sequence data at several positions, including a frameshift in the carboxy terminus which cancels the RGD motif and extends the capsid ORF by 27 amino acis. This sequence was confirmed by protein sequencing of proteolytic fragments of VP3. Thus, the virus mutant (pTAV-p), in which the intention was to exchange D of the putative RGD motif for E, resulted in replacing I480 by S in the newly established ORF. A second virus mutant (pTAV-d), in which the intention was to delete the RGD peptide, in fact gave a shift into the ORF of the originally published sequence. The pTAV-p mutant showed a strongly reduced infectivity compared to wild-type AAV-2, whereas pTAV-d was not infectious at all. Neither mutant accumulated viral ssDNA as detected by Hirt extraction. Analysis of virus particle formation and subcellular localization of the capsid proteins revealed a defect of the mutant capsid proteins in capsid assembly. This shows that the newly established C-terminal sequence of the AAV capsid proteins plays an important role in viral assembly.
Present address: Hoffmann-LaRoche, Pharmaceutical Research, Preclinical Genetechnology 66/709, Grenzacher Straße, CH4002 Basel, Switzerland.
Received 16 May 1994;
accepted 29 July 1994.
This article has been cited by other articles:
|
|
 |
|
  V. J. McAlister and R. A. Owens Preferential Integration of Adeno-Associated Virus Type 2 into a Polypyrimidine/Polypurine-Rich Region within AAVS1 J. Virol., September 15, 2007; 81(18): 9718 - 9726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Lochrie, G. P. Tatsuno, B. Christie, J. W. McDonnell, S. Zhou, R. Surosky, G. F. Pierce, and P. Colosi Mutations on the External Surfaces of Adeno-Associated Virus Type 2 Capsids That Affect Transduction and Neutralization J. Virol., January 15, 2006; 80(2): 821 - 834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bleker, F. Sonntag, and J. A. Kleinschmidt Mutational Analysis of Narrow Pores at the Fivefold Symmetry Axes of Adeno-Associated Virus Type 2 Capsids Reveals a Dual Role in Genome Packaging and Activation of Phospholipase A2 Activity J. Virol., February 15, 2005; 79(4): 2528 - 2540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Warrington Jr., O. S. Gorbatyuk, J. K. Harrison, S. R. Opie, S. Zolotukhin, and N. Muzyczka Adeno-Associated Virus Type 2 VP2 Capsid Protein Is Nonessential and Can Tolerate Large Peptide Insertions at Its N Terminus J. Virol., June 15, 2004; 78(12): 6595 - 6609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-G. Zhang, J. Xie, I. Dmitriev, E. Kashentseva, D. T. Curiel, H.-C. Hsu, and J. D. Mountz Addition of Six-His-Tagged Peptide to the C Terminus of Adeno-Associated Virus VP3 Does Not Affect Viral Tropism or Production J. Virol., October 25, 2002; 76(23): 12023 - 12031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Xie, W. Bu, S. Bhatia, J. Hare, T. Somasundaram, A. Azzi, and M. S. Chapman The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy PNAS, August 6, 2002; 99(16): 10405 - 10410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yoon, D. H. Smith, P. Ward, F. J. Medrano, A. K. Aggarwal, and R. M. Linden Amino-Terminal Domain Exchange Redirects Origin-Specific Interactions of Adeno-Associated Virus Rep78 In Vitro J. Virol., April 1, 2001; 75(7): 3230 - 3239. [Abstract] [Full Text]
|
|
|
|
|
|
P. Wu, W. Xiao, T. Conlon, J. Hughes, M. Agbandje-McKenna, T. Ferkol, T. Flotte, and N. Muzyczka Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism J. Virol., September 15, 2000; 74(18): 8635 - 8647. [Abstract] [Full Text]
|
|
|
|
|
|
U. Bantel-Schaal, H. Delius, R. Schmidt, and H. zur Hausen Human Adeno-Associated Virus Type 5 Is Only Distantly Related to Other Known Primate Helper-Dependent Parvoviruses J. Virol., February 1, 1999; 73(2): 939 - 947. [Abstract] [Full Text]
|
|
|
|
|
|
R. H. Smith and R. M. Kotin The Rep52 Gene Product of Adeno-Associated Virus Is a DNA Helicase with 3'-to-5' Polarity J. Virol., June 1, 1998; 72(6): 4874 - 4881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Rutledge, C. L. Halbert, and D. W. Russell Infectious Clones and Vectors Derived from Adeno-Associated Virus (AAV) Serotypes Other Than AAV Type 2 J. Virol., January 1, 1998; 72(1): 309 - 319. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
